We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
The association and VHIR have signed a collaboration agreement to fund with 150,000€ a project to find new therapeutic strategies for this childhood tumor of the central nervous system.
Pulseras Candela and the Vall d'Hebron Research Institute (VHIR) have signed a new collaboration agreement to fund with 150,000€ over three years the project "New therapeutic approaches for the treatment of pediatric ependymoma". The partnership makes possible this study, led by the laboratory of Dr. Miquel Segura, principal investigator of the Childhood Cancer and Blood Disorders group at VHIR.
According to Dr. Miquel Segura, "the commitment of Pulseras Candela for the fourth consecutive year is essential to consolidate and advance in the research of one of the rare and highly aggressive brain tumors".
On its part, for the association Pulseras Candela, "it is a great pride to be able to re-sign an agreement like this, and that for 6 years part of this line of research will be supported thanks to our contribution, and with the hope that Dr. Miquel Segura and his team will be able to find treatments for this disease in the future".
Research in pediatric ependymoma in Vall d'Hebron
Pediatric ependymoma is a type of childhood tumor that affects the central nervous system of affected patients and is incurable in approximately 40% of cases. Its treatment is based on surgery accompanied by radiotherapy or chemotherapy, but is usually limited by its complicated location and the risk of damaging vital brain structures. The development of new therapies is key to improving quality of life and survival. In this sense, the project led by the Childhood Cancer and Blood Disorders group at VHIR has the following objectives:
The Pulseras Candela association was born in 2013, when Candela, a girl with leukemia, began making bracelets with her friends and the children and adolescents who shared a floor in the hospital with her. Their families created the association to preserve their solidarity project and encourage research to improve the treatment and survival of patients, along with the collaboration of volunteers, companies and the whole society that has led this project to be one of the main promoters of childhood cancer research in our country.
Paediatric Oncology and Haematology,
Children's Hospital and Woman's Hospital
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to email@example.com, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.